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Abstract
The etiology of the vast majority of Parkinson’s disease (PD) cases is unknown. It is generally accepted that there is an
interaction between exposures to environmental agents with underlying genetic sensitivity. Recent epidemiological studies
have shown that people living in agricultural communities have an increased risk of PD. Within these communities, paraquat
(PQ) is one of the most utilized herbicides. PQ acts as a direct redox cycling agent to induce formation of free radicals and
when administered to mice induces the cardinal symptoms of parkinsonism, including loss of TH+-positive dopaminergic
(DA) neurons in the ventral midbrain’s substantia nigra pars compacta (SNpc). Here we show that PQ-induced SNpc neuron
loss is highly dependent on genetic background: C57BL/6J mice rapidly lose ,50% of their SNpc DA neurons, whereas
inbred Swiss-Webster (SWR/J) mice do not show any significant loss. We intercrossed these two strains to map quantitative
trait loci (QTLs) that underlie PQ-induced SNpc neuron loss. Using genome-wide linkage analysis we detected two
significant QTLs. The first is located on chromosome 5 (Chr 5) centered near D5Mit338, whereas the second is on Chr 14
centered near D14Mit206. These two QTLs map to different loci than a previously identified QTL (Mptp1) that controls a
significant portion of strain sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), suggesting that the
mechanism of action of these two parkinsonian neurotoxins are different.
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Introduction
Parkinson’s disease (PD) is the third most common neurode-
generative disorder, affecting approximately two percent of the
adult population older than 55 years. The underlying cause for the
vast majority of PD cases is unknown. Controversy still exists as to
how much of the disease results from strictly genetic factors,
environmental factors, or an interaction of both [1,2,3]. Empirical
evidence suggests that less than 10% of all diagnosed Parkinsonism
has a strict familial etiology [4]. One mechanism related to
environmental exposure that has been proposed in PD’s etiology is
the abnormal handling of free radical species; whether by excessive
generation of these species or inability to handle their detoxifica-
tion [5,6]. Several animal models of PD that utilize xenobiotics
have been developed; each mimicking aspects of parkinsonism.
These include administration of 1-methyl-4-phenyl-1,2,3,6-tetra-
hydropyridine (MPTP), rotenone or 1,19 di methyl-4,49-bipyr-
idium dichloride (paraquat, PQ). Each of these toxins generates
free radicals, although the mechanism(s) by which this occurs is
different. MPTP and rotenone generate oxidative stress through
generation of free radicals after blockade of complex 1 in the
mitochondrial electron transport chain [7]. Paraquat also
generates free radicals, but through direct redox cycling [8,9].
Only specific strains of mice are sensitive to the administration
of MPTP [10,11,12]. The differential effects of xenobiotics on
CNS, including environmental and chemical toxins such as MPTP
and PQ, are likely influenced by the interaction of multiple gene
products. The cumulative phenotypes that arise from both
environmental factors and polygenic interactions among gene
variants are termed quantitative traits. Chromosomal regions that
harbor crucial gene variants that modulate risk are called
quantitative trait loci (QTLs) [13]. The premise behind QTL
mapping is that if numerous genetic markers are examined, only
those that cosegregate with a particular phenotype variant, for
example,high or low susceptibility,willbelinkedtothe gene variants
that underlie that trait [14]. Previously, we have shown that the
effects of MPTP on SNpc neuron loss are strain specific. The very
well characterized C57BL/6J strain is highly sensitive to this
compound whereas the common Swiss–Webster inbred strain
(SWR/J) is resistant. Through a genome-wide analysis of C57BL/
6J6SWR backcross progeny we mapped a QTL for MPTP-induced
SNpcneuron loss named Mptp1 nearthe distal endofChr 1 between
D1Mit113 and D1Mit293. This locus accounts for the majority of the
strain sensitivity to MPTP [15]. In order to determine if genes
involvedincontrollingDAneuronlossaresimilarinMPTPandPQ-
induced neurodegeneration, we identified QTLs for PQ loss again
exploiting the same strain difference. Our findings suggest that there
are also marked strain-specific effects of PQ on SNpc dopaminergic
neuron number loss, and that the genetic influence underlying PQ-
induced neurons loss are different than those seen with MPTP.
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All of the experimental procedures in the animals were
performed in accordance with the NIH Guide for the Care and
Use of Laboratory Animals and all protocols, were approved by
the St Jude Children’s Research Hospital IACUC (protocol 270).
Experiments were carried out in accordance with The Code of
Ethics of the World Medical Association (Declaration of Helsinki)
for animal experiments.
Male and female C57BL/6J and SWR/J mice were purchased
from the Jackson Laboratory (Bar Harbor, ME). F1 crosses were
generated by mating male C57BL/6J with female SWR/J and
female C57BL/6J with male SWR/J stock. F1 hybrids were
backcrossed to SWR/J to generate a set of 61 backcross (N2)
progeny that were used to map QTLs. All animals were housed
within the vivarium at St. Jude Children’s Research Hospital and
were maintained on a 12:12 hour light:dark cycle with ad libitum
food and water.
Paraquat treatment
1,19 di methyl-4,49-bipyridium dichloride (paraquat, PQ)
(catalog 36541 Sigma-St. Louis, MO) was dissolved in sterile
saline to a final concentration of 20 mg/ml. Each animal was
given a total of 60 mg/kg of PQ, using a dosage regimen of
10 mg/kg62 per week for 3 weeks. All mice that survived the
injection protocol were sacrificed one week after the final PQ
administration.
Histology
Mice were anesthetized with an overdose of Avertin. Following
induction of deep anesthesia determined by loss of deep tendon
and corneal reflexes, animals were transcardially perfused with
physiologic saline followed by 3% paraformaldehyde in 1X
phosphate-buffered saline (PBS), pH 7.4. Brains were removed
from the calvaria and post-fixed overnight in fresh fixative,
dehydrated through a graded series of ethanols, defatted in mixed
xylenes and embedded in Paraplast-X-tra (Fisher Scientific,
Pittsburgh, PA). Brains were subsequently blocked and serially
sectioned at 10 microns in the coronal plane. All sections from the
rostral hippocampus to the cerebellar-midbrain junction was saved
and mounted onto Superfrost-Plus slides (Fisher Scientific).
Standard immunhistochemical techniques using a polyclonal
antibody directed against tyrosine hydroxylase (TH) (1:250 in
blocking buffer; Pel Freez, Rogers, AR) were to identify
dopaminergic neurons in the SNpc as previously described [15].
Slides were then counterstained with Neutral Red, dehydrated
through a graded series of alcohol, mounted in Permount and
coverslipped.
DA Cell Quantification and Analysis
Dopaminergic neurons in the SNpc were quantified using
stereological methods described previously [16]. Statistical anal-
yses were done using Student’s t-test (GraphPad Prism V, La Jolla,
CA).
Microsatellite markers
To identify and map QTLs, we used a set of polymorphic MIT
microsatellite markers (Table 1) that previously have been shown
to differentiate C57BL/6J from SWR/J [15]. DNA samples from
each mouse were amplified using PCR thermal cycling parameters
described in detail at www.nervenet.org/papers/PCR.html. We
used a touchdown PCR protocol to improve the specificity of
annealing. The products were all run on Metaphor agarose,
photographed, and scored manually. Data were entered into a
relational database (FileMaker Pro).
Calculating linkage between loci
We compared the distribution pattern of phenotypes of the mice
(high or low SNpc number following PQ treatment) with the
distribution pattern of sensitive (C57BL/6J=B) and resistant
(SWR/J=S) alleles at each of the polymorphic microsatellite loci.
The first level of analysis was simply to detect a linkage using a
constrained additive regression model whereas the second level
involved estimating QTL position more precisely by interval
mapping. Actual calculations were performed using the program
Map Manager QTX b29 [17].
Microarray Analysis
Four- to six-month old C57BL/6J and SWR/J mice were
deeply anesthesized, and when deep tendon and corneal reflexes
they were absent rapidly decapitated. The substantia nigra
(Bregma: 22.70 to 23.70) and striatum (Bregma: +0.14 to
+1.26 mm) [18] were rapidly dissected, flash frozen and stored at
280uC. mRNA was isolated from SN and striatum in accordance
with the protocol outlined in RNAqueous Micro kit (Ambion,
Austin, TX) according to manufacturers recommendations.
Technical procedures for microarray analysis, including quality
control of mRNA, labeling, hybridization and scanning of the
arrays were performed by the Hartwell Center for Bioinformatics
& Biotechnology (HC) at St. Jude Children’s Research Hospital
(SJCRH) according to standard operating procedures for Affyme-
trix protocols (GeneChip Expression Analysis manual, Affymetrix,
Santa Clara CA, USA).
The GeneChip HT MG-430 PM array plate (Affymetrix)
containing 45,037 probe sets were used in this study. These arrays
represent 39,000 transcripts. Scanned images of processed arrays
were analyzed with the Gene Chip Operating Software
(GCOSv1.2, Affymetrix). Assessment of probe set present/absent
calls was made using the Single Array Analysis method using the
statistical algorithm with default analysis parameters as detailed in
http://media.affymetrix.com/support/technical/whitepapers/ht_
system_whitepaper.pdf. Expression levels of genes located within
the QTL regions were queried and those having a difference
in expression (625%) and a significance of p,0.001 were
identified.
Results
Strain specific Effects of PQ on SNPC dopaminergic
neuron number
We compared the effects of PQ on the severity of SNpc
dopaminergic neuron loss in C57BL/6J and SWR/J strains. We
have previously shown that these strains were respectively
susceptible and resistant to MPTP-induced SNpc dopamine
neuron loss [19]. We find that there is a strain-dependent
sensitivity to PQ-induced SNpc neuron loss, and that C57BL/6J
lose ,48% of SNpc dopaminergic neurons, whereas SWR/J show
a much less and insignificant 8% loss (Figure 1).
Identification of QTL’s underlying strain dependent PQ –
induced SNpc neuron loss
To identify quantitative trait loci responsible for PQ-induced
strain dependent SNpc DA neuron loss, we used stereological
procedures to estimate the number of SNpc DA neurons in 61
C57BL/6J6SWR/J N2 progeny. Only C57BL/6J6SWR/J F1
mice are sensitive to PQ, and we therefore crossed C57BL/
Paraquat QTL
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progeny that will be B/S heterozygotes or S/S homozygous at
each locus. Genotypes were entered for each marker and
correlated to two phenotypes: (1) the overall phenotypic severity
treated as a Mendelian score (affected or unaffected), and (2) the
number of SNpc DA neurons [15]. We found two significant
(genome-wide P,0.001) chromosomal loci using the Mendelian
correlation with a 20 cM sensitivity, and the program Map
Manager QTX b29 based on 10,000 permutation analysis, located
on Chr 5 centered near D5Mit338 (Chr5, <109 Mb, all genome
positions are based on the NCBI37/mm9 mouse genome
assembly) (Fig. 2A) and on Chr 14 centered near D14Mit206
(Chr 14, <21.5 Mb) (Figure 2B)(Table 1). The same loci were
found using the numerical data.
The QTL on Chr 5 overlaps 88 coding genes whereas that on
Chr 14 overlaps 28 coding genes (as delineated by Ensembl).
Based on our analysis of array data, the majority of these genes (93
of 116) have detectible expression in either striatum or substantia
nigra in C57BL/6J and SWR/J. Of 88 identified genes located on
Chr 5 between 99 and 119 Mb, 31 were differentially expressed by
more than 25% between strains (p,0.001, Table S1) in striatum.
Only five genes met the same criterion on the Chr 14 interval
between 16.4 and 26.6 Mb (Table S2). In addition to the identified
coding genes, the Ensembl database also identified a sequence on
Chr 5 between 117.082490 and 117.083614 Mb. that corresponds
to a glutathione S-transferase Mu pseudogene (GSTm2-ps1).
Discussion
In this study we report that the C57BL/6J and SWR/J strains
are differentially sensitive to systemic administration of paraquat—
a finding that supports previous studies that detail differential
genetic effects of this herbicide [20] and other neurotoxins,
including MPTP [12,19,21,22,23]. We have exploited this
pronounced strain difference to map chromosomal regions that
modulate the differential vulnerability of dopaminergic cell to PQ.
Unlike studies of Parkinson’s disease in humans, we can carefully
control both genetic and environmental factors and efficiently
generate precise estimates of the loss of DA neurons in inbred
parental strains and backcross progeny. As shown here, the
Table 1. List of Microsatellite Markers and Mendelian Correlations.
MIT marker cM Mendelian Correlation MIT marker cM Mendelian Correlation
D1Mit211 10.59 0.013 D11Mit78 10.44 0.247
D1Mit100 62.56 0.023 D11Mit5 40.59 0.142
D1Mit293 97.55 0.064 D11Mit334 74.06 0.169
D2Mit416 12.00 0.009 D12Mit169 7.03 0.352
D2Mit458 29.62 0.092 D12Mit214 37.86 0.253
D2Mit311 86.12 0.069 D12Mit280 60.94 0.392
D3Mit240 15.80 0.221 D13Mit106 47.75 0.362
D3Mit51 26.20 0.253 D13Mit254 40.95 0.392
D3Mit19 66.70 0.198 D13Mit78 67.21 0.253
D4Mit192 13.50 0.299 D14Mit206 11.53 0.429
D4Mit78 61.15 0.197 D14Mit262 37.20 0.247
D4Mit13 75.67 0.121 D14Mit266 64.86 0.090
D5Mit233 28.55 0.250 D15Mit53 6.29 .0256
D5Mit338 52.23 0.428 D15Mit229 16.31 0.310
D5Mit287 89.18 0.325 D15Mit161 52.78 0.203
D6Mit273 22.51 0.143 D16Mit181 2.90 0.066
D6Mit146 43.05 0.101 D16Mit4 25.43 0.034
D6Mit291 66.78 0.169 D16Mit106 57.68 0.067
D7Mit117 17.26 0.041 D17Mit30 14.26 0.037
D7Mit238 63.78 0.169 D17Mit139 27.40 0.352
D7Mit259 88.85 0.250 D17Mit42 50.30 0.066
D8Mit95 12.47 0.172 D18Mit223 6.60 0.037
D8Mit205 28.85 0.218 D18Mit188 45.88 0.253
D8Mit121 72.27 0.170 D18Mit213 57.33 0.351
D9Mit205 20.75 0.168 D19Mit90 35.97 0.233
D9Mit32 36.41 0.196 D19Mit137 54.60 0.221
D9Mit116 59.58 0.305 DXMit166 28.26 0.175
D10Mit247 5.81 0.231 DXMit68 29.49 0.260
D10Mit186 38.56 0.325 DXMit117 53.75 0.314
D10Mit292 55.33 0.196
D10Mit297 72.31 0.037
doi:10.1371/journal.pone.0029447.t001
Paraquat QTL
PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e29447parental strain difference can be dissected into a small number of
QTLs and candidate genes.
PQ is one of the most commonly used pesticides in the
agricultural community. Its mechanism of action involves the
transfer of an electron (usually from NADPH) to form a PQ+
radical. This free radical interacts with molecular oxygen to form a
superoxide radical that damages lipids contained within cell
membranes [24]. PQ has been shown to induce extensive
mitochondrial oxidative damage [25,26]. In the brain, PQ is
actively transported through neutral amino acid transporters [27]
and its use has been linked to an increased risk for developing
Parkinson’s disease [28,29,30]. Experimentally, systemic adminis-
tration of paraquat induces a relatively specific lesion in the SNpc
that results in dopaminergic neuron loss [20,31,32]. Mechanisti-
cally, it has been proposed that this selective cell loss occurs by
virtue of the SNpc having 1) significant dopamine metabolism
[33], 2) a significantly increased microglial density compared to
other brain regions [34], and 3) an increased concentration of iron
which results in a propensity to form intracellular hydrogen
peroxide and superoxides [35] that can initiate apoptosis through
a BAK dependent mechanism [36]. Although these cellular
mechanisms have been hypothesized, the gene(s) underlying them
have not been identified.
Our analysis identified two QTLs for PQ senstivity; one located
within a 20 cM (100,120 Mb) interval of Chr 5 and the other
within a 20 cM (15,35 Mb) interval of Chr 14. To better define
genes in these regions that may contribute to differential sensitivity
to PQ-induced SNpc neuronal loss we used several criteria. First,
we used an unbiased approach to identify genes that are
differentially expressed in the substantia nigra and striatum of
the parental strains. Although a number of genes meet our criteria
of a 25% difference in expression, we further filtered results based
upon the known function of the genes and possible relations to a
function that could modulate PQ effects. We also flagged any
candidates identified in previous genome-wide association studies
of humans. The latter approach highlighted diacylglycerol kinase,
theta 110 kDa (DGKQ), a gene that has a strong association in
patients of Dutch decent with familial [37] and sporadic [38]
Parkinson’s disease Inhibition of DGKQ activity attenuates the
binding of SF1 to the CYP17 promoter, subsequently inhibiting
cAMP-dependent CYP17 transcription. CYP17 is a member of the
P450 proteins that function as xenobiotic metabolizing enzymes
Figure 1. Paraquat-induced cell loss is strain dependent. (A) After chronic PQ administration, we find that C57BL/6J have a <50% decrease in
SNpc DA neurons, while SWR have a <10% loss of SNpc neurons. (B) TH-immunostained section through rostral SNpc of C57BL/6J mouse. Box is seen
at higher magnification in (C). (D) Following chronic administration of PQ to C57BL/6J mice, there is a loss of both DA neurons and fibers. Box is seen
at higher magnification in (E). (F). TH-immunostained section through rostral SNpc of SWR mouse. Box is seen at higher magnification in (G). (H)
Following chronic administration of PQ to SWR mice, there is a no apparent loss of DA neurons or fibers. Box is seen at higher magnification in (E).
doi:10.1371/journal.pone.0029447.g001
Figure 2. Chromosomal maps showing the identified QTL regions. A 20 cM region (red box) on the distal are of mCHr 5 and the proximal
arm of mChr14 were identified by QTL analysis.
doi:10.1371/journal.pone.0029447.g002
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system [40]. Other genes within the QTL were implicated by their
known function; where modulation of these activities have been
implicated in the pathogenesis of Parkinson’s disease. Examples of
these genes include Spp1 and Hspb8, each of which has been
implicated in the inflammatory, oxidative, and nitrosylative stress
response to insult [41]. Spp1 encodes the osteopontin protein that
is expressed in the SNpc [42] and its absence has been shown to be
neuroprotective in the MPTP model of experimental parkinsonism
[43]. Hspb8 encodes a heat shock protein that forms a complex
BAG3 [44]. When overexpressed, this HSPB8-BAG3 complex
functions in the clearance of mutated aggregation-prone proteins
including alpha-synuclein [45], whose accumulation is a hallmark
of Parkinson’s disease [46].
Other genes in these QTLs function in processes thought to be
important to neuronal survival following injury. There is higher
expression in genes involved in energy production and gluconeo-
genesis in the SN, where their gene products function to increase
production of ATP, and indirectly (Adk) or directly (Hscb)
contribute to protection from oxidative stress [44,47,48]—a
critical process in SNpc DA neuroprotection [5,49,50]. Addition-
ally, Ppp3cb, which encodes a subunit the calcineurin, is a protein
that is highly expressed in the SN [51] and functions as a
phosphatase that modulates synaptic plasticity and cell death
[52,53]. Lower levels of the citron mRNA are seen in both SN and
striatum of SWR mice exposed to PQ compared to C57BL/6J.
Citron acts as a rho/rac binding protein that regulates activity of
RhoA. Inhibition of RhoA is associated with repair of axonal
processes [54] and has been shown to increase its expression in
brain after treatment with the complex I inhibitor rotenone [55].
Conversely, citron levels are reduced in animals exposed to
environmental enrichment [56], which has been shown to be
neuroprotective [57].
A third class of genes differentially expressed between C57BL/
6J and SWR/J following PQ administration are in the
inflammatory pathway. Nos1, a gene encoding neuronal nitric
oxide synthase, functions to catalyze the production of nitric oxide
(NO) from L-arginine. Inhibition of nNOS in neuronal cells lines
increases the toxicity of MPP+ [58], suggesting that the higher
mRNA expression levels seen in the SWR striatum would be
neuroprotective.
We also noted the presence of sequence within the Chr 5 QTL
that encodes a sequence that appears to be glutathione S-
transferase mu (Gstm1) pseudogene. Pseudogenes resemble their
cognate genes, but for the most part are not translated into
functional proteins. Although they often lack introns, likely as a
function of their generation through retrotransposition, these
sequences are not likely to be ‘‘junk DNA’’ as previously thought
[59]. Recent evidence suggests that they can play a role in the
regulation of their related coded gene [60,61,62]. Gstm1 is a
member of the GST superfamily, that function as phase II
detoxification enzymes that catalyze the conjugation of glutathione
and electrophiles [63]. Gstm1 is one of seven members in a closely
associated gene cluster located on mouse Chr3 [64]. Gstm1 is
expressed in brain [65], and in the substantia nigra is seen in both
dopaminergic neurons and astrocytes [66] and has been
implication in control of dopamine metabolism [67] that could
have implications in the etiology of Parkinson’s disease.
In a previous QTL examining sensitivity to the parkinsonian
agent MPTP, we identified a single QTL called Mptp1, located on
Chr1 [15] and a strong candidate gene, glutathione S-transferase
pi (Gstp1). Gstp1 is a member of the same GST superfamily as
Gstm1 and also functions as a phase II detoxification enzyme. The
location of the two significant QTLs in this study do not map to
the Mptp1 QTL, although the same two mouse strains show a
similar phenotype after treatment with MPTP and PQ including
loss of DA neurons and induction of micro-and astrogliosis. This
difference is, however, not unexpected since the mechanism of
action of MPTP, which involves blockade of complex I of the
electron transport chain leading to generation of free radicals [68],
has been shown to be different from PQ, which is a direct redox
generator [8]. It would be interesting to determine if the effects of
these two xenobiotics are synergistic, suggesting that there are
independent populations of SNpc dopamine neurons that are
sensitive to different xenobiotic insults and thus different
interventions would be necessary for each xenobiotic. However,
if PQ, MPTP or other exogenous agents (i.e. rotenone) kill the
same populations of SNpc dopamine neurons, independent of the
mechanism that initiates the cell death, one could concentrate on
developing a general therapy to reduce oxidative stress in the brain
as a method for protecting against or slowing the progress of the
SNpc dopamine neuron death.
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